Comparison of two-risk assessment algorithms for preeclampsia in first trimester with consecutive intake of low-dose aspirin in the high-risk group - an observational study.
We analyzed outcome of women screened for preeclampsia with two different multifactorial risk algorithms (Predictor®Software by PerkinElmer, PerkinElmer, Waltham, MA; PERK-group:n = 214 and Viewpoint®by GE Healthcare, Dornstadt, Germany; VIEW-group:n = 209) in first trimester. Women at high risk for...
| Publicado en: | Journal of Maternal-Fetal & Neonatal Medicine Vol. 31; no. 5; pp. 549 - 553 |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | research Journal Article |
| Publicado: |
Taylor & Francis Ltd
Mar2018
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=127676712&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 127676712 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 14767058 O6A jtl: Journal of Maternal-Fetal & Neonatal Medicine issn: 14767058 maglogo: Y pubinfo: dt: Mar2018 vid: 31 iid: 5 pid: 377 pub: Taylor & Francis Ltd place: Philadelphia, Pennsylvania artinfo: ui: 127676712 127676712 NLM28162023 127676712 10.1080/14767058.2017.1291621 NLM28162023 127676712 ppf: 549 ppct: 4 formats: tig: atl: Comparison of two-risk assessment algorithms for preeclampsia in first trimester with consecutive intake of low-dose aspirin in the high-risk group - an observational study. aug: au: Lakovschek, Ioana-Claudia Csapo, Bence Kolovetsiou-Kreiner, Vassiliki Mayer-Pickel, Karoline Reif, Philipp Stern, Christina Ulrich, Daniela Lang, Uwe Obermayer-Pietsch, Barbara Cervar-Zivkovic, Mila affil: Division of Obstetrics, Department of Obstetrics and Gynaecology, Medical University of Graz, Graz, Austria sug: subj: Pregnancy Trimester, First Aspirin Administration and Dosage Decision Support Techniques Pre-Eclampsia Diagnosis Algorithms Platelet Aggregation Inhibitors Administration and Dosage Platelet Aggregation Inhibitors Therapeutic Use Aspirin Therapeutic Use Retrospective Design Human Risk Factors Risk Assessment Pre-Eclampsia Prevention and Control Female Pregnancy Treatment Outcomes Validation Studies Comparative Studies Evaluation Research Multicenter Studies Female ab: We analyzed outcome of women screened for preeclampsia with two different multifactorial risk algorithms (Predictor®Software by PerkinElmer, PerkinElmer, Waltham, MA; PERK-group:n = 214 and Viewpoint®by GE Healthcare, Dornstadt, Germany; VIEW-group:n = 209) in first trimester. Women at high risk for developing preeclampsia were advised to take low-dose acetylsalicylic acid (LDA). Screening positive rates for early onset preeclampsia differed significantly between the two groups (7.9% versus 26.3%;p = 0.000). According the clinical use of screening test criteria, LDA was prescribed in 63 (29.4%) women in the PE-group and 55 (26.3%) in the VP-group (p = 0.516). There were no differences in onset of preeclampsia [4 (1.9%) versus 6 (2.9%);p = 0.540]. No early or severe preeclampsia occurred in the whole population. pubtype: Academic Journal doctype: research Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|